Table 2 Laboratory and radiological characteristics of the Omicron BA.5.2 and prototype patients

N

157

199

SpO₂ (%)

92.50 ± 15.00

97.51 ± 1.48

4.403

< 0.001

CT

142.600

< 0.001

 No pneumonia

2 (1.3%)

118 (59.3%)

 Ground-glass opacity

30 (19.1%)

13 (6.5%)

 Local/Bilateral patchy shadowing

107 (68.2%)

68 (34.2%)

consolidation

18 (11.5%)

0 (0.0%)

White-cell count (×10⁹·L^-1)

19.080

< 0.001

 ≥ 10

19 (12.1%)

3 (1.5%)

 ≥ 4, < 10

125 (79.6%)

167 (83.9%)

 < 4

13 (8.3%)

29 (14.6%)

Lymphocyte count (×10⁹·L^-1)

19.980

< 0.001

 ≥ 4

2 (1.3%)

0 (0.0%)

 ≥ 0.8, <4

97 (61.8%)

80 (40.2%)

 < 0.8

58 (36.9%)

119 (59.8%)

Platelet count (×10⁹·L^-1)

39.740

< 0.001

 ≥ 300

4 (2.5%)

5 (2.5%)

 ≥ 100, < 300

112 (71.3%)

187 (94.0%)

 < 100

41 (26.1%)

7 (3.5%)

Hematocrit (%)

 (< 40 (male), < 35 (female))

98 (62.4%)

15 (7.5%)

112.000

< 0.001

CRP (> 8 mg.L^-1)

111 (70.7%)

73 (36.7%)

40.670

< 0.001

D-dimer (> 0.55 mg.L^-1)

104 (66.2%)

8 (4.0%)

157.600

< 0.001

PT (second)

11.20 ± 1.68

10.46 ± 0.82

7.234

< 0.001

INR

1.00 ± 0.15

0.91 ± 0.09

4.727

< 0.001

Liver function

 PA (< 200 mg.L^-1)

128 (81.5%)

33 (16.6%)

114.800

< 0.001

 ALB (< 35 g.L^-1)

65 (41.4%)

1 (0.5%)

100.100

< 0.001

 TB (> 20.4 umol.L^-1)

53 (33.8%)

13 (6.5%)

42.220

< 0.001

 ALT (> 40 U.L^-1)

79 (50.3%)

22 (11.1%)

88.610

< 0.001

 AST (> 42 U.L^-1)

59 (37.6%)

19 (9.5%)

40.770

< 0.001

 LDH (> 240 U.L^-1)

72 (45.9%)

3 (1.5%)

64.250

< 0.001

 GGT (> 50 U.L^-1)

61 (38.9%)

30 (15.1%)

10.490

0.001

 ALP (> 128 U.L^-1)

13 (8.3%)

3 (1.5%)

8.635

0.003

 CHE (> 3700 U.L^-1)

23 (14.6%)

0 (0.0%)

17.500

< 0.001